Cann Group Limited logo

Cann Group Limited (CAN)

Market Closed
ASX ASX
- Market Cap
- P/E Ratio
- Div Yield
1.17M Volume
0 Eps
Want to track CAN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CAN is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0067%, based on the last three reports.
Cann Group Limited has completed 1 stock splits, with the recent split occurring on Jun 19, 2023.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on CXA (AUD).

Cann Group Limited (CAN) FAQ

On which exchange is it traded?

Cann Group Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is CAN.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Cann Group Limited ever had a stock split?

Cann Group Limited had 1 splits and the recent split was on Jun 19, 2023.

Cann Group Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
Jennifer Lee Pilcher CEO
ASX Exchange
Q2045T101 CUSIP
AU Country
98 Employees
- Last Dividend
19 Jun 2023 Last Split
- IPO Date

Overview

Cann Group Limited is a pioneering company that specializes in the breeding, cultivation, production, manufacturing, supplying, and selling of medicinal cannabis. Founded in the year 2014, it has carved a niche for itself in the medicinal cannabis industry. The company boasts licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. Headquartered in Port Melbourne, Australia, Cann Group Limited stands at the forefront of the medicinal cannabis sector, contributing significantly to research and development in this evolving field.

Products and Services

  • Medicinal Cannabis Cultivation:

    Cann Group Limited focuses on the breeding and cultivation of cannabis strains specifically tailored for medicinal purposes. Their cultivation practices are designed to produce high-quality cannabis plants that meet the stringent requirements of medicinal cannabis products.

  • Production and Manufacturing:

    In addition to cultivation, the company is involved in the production and manufacturing of medicinal cannabis. This includes the extraction of active pharmaceutical ingredients (APIs) and the creation of various medicinal cannabis products that adhere to pharmacological standards.

  • Supplying and Selling Medicinal Cannabis:

    Cann Group Limited is also engaged in the supplying and selling of medicinal cannabis, making their high-quality products available to patients in need. Their comprehensive supply chain ensures that medicinal cannabis reaches patients through legal and regulated channels.

  • Research and Development:

    With a license to undertake research, Cann Group Limited is deeply invested in advancing the scientific understanding of cannabis for medicinal use. Their research efforts aim to innovate and enhance the effectiveness, safety, and accessibility of medicinal cannabis treatments.

Contact Information

Address: 262-276 Lorimer Street
Phone: 61 3 9095 7088